Ro Launches Wegovy Pill Through Integration with Novo Nordisk Ro to play critical role in ensuring patients nationwide get access to first and only oral GLP-1 weight loss medication at the lowest available cash price January 5, 2026 -- Ro, the leading direct-to-patient healthcare company, announced today that it is working with Novo Nordisk on the nationwide launch of the new Wegovy pill
Adequate dietary protein, progressive resistance training, metabolic optimization, and sleep quality all synergize with peptide interventions
Kuruvilla M, Gurk-Turner C
MAKES YOUR WORKOUTS MORE EFFICIENT: BCAAs are glucogenic amino acids that serve as an immediate source of energy during workouts
Were excited to work with Lilly to offer the newest GLP-1 pill on the market, said Zach Reitano, co-founder and CEO of Ro, in the announcement
IVIM includes group coaching, one-on-one virtual holistic consultations, nutrition coaching with customized diet plans through its app, and an extensive patient community in the portal
